Evolent Health, Inc (EVH) News
Filter EVH News Items
EVH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
EVH News Highlights
- For EVH, its 30 day story count is now at 4.
- Over the past 20 days, the trend for EVH's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about EVH are HUM.
Latest EVH News From Around the Web
Below are the latest news stories about EVOLENT HEALTH INC that investors may wish to consider to help them evaluate EVH as an investment opportunity.
Centene completes sale of benefit management subsidiary to Evolent HealthWith the deal's close, Clayton-based health care giant Centene launches a multiyear partnership with Virginia-based Evolent Health. |
Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term... |
Evolent spikes as Humana partnership expandsEvolent Health (EVH), a service provider focused on value-based care, added ~8% on Thursday after announcing an expansion to its collaboration with Humana (HUM). Read the full story here. |
Is There Now An Opportunity In Evolent Health, Inc. (NYSE:EVH)?While Evolent Health, Inc. ( NYSE:EVH ) might not be the most widely known stock at the moment, it received a lot of... |
Are Investors Undervaluing Evolent Health, Inc. (NYSE:EVH) By 48%?Does the December share price for Evolent Health, Inc. ( NYSE:EVH ) reflect what it's really worth? Today, we will... |
Evolent Health, Inc – Consensus Indicates Potential 47.4% UpsideEvolent Health, Inc found using ticker (EVH) have now 8 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 57 and 32 and has a mean target at 42.25. Now with the previous closing price of 28.66 this indicates there is a potential upside of 47.4%. The 50 day moving average now sits at 29.85 while the 200 day moving average is 31.04. The company has a market capitalisation of $2,759m. You can visit the company''s website by visiting: https://www.evolenthealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EVH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,068m based on the market concensus. Evolent Health, a healthcare company, through its subsi... |
Evolent Health to Participate in Upcoming ConferencesEvolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer Seth Blackley, Chief Financial Officer John Johnson and Vice President, Investor Relations Seth Frank will participate in upcoming investor conferences. |
Evolent Health, Inc – Consensus Indicates Potential 52.6% UpsideEvolent Health, Inc found using ticker (EVH) now have 8 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 57 and 32 calculating the average target price we see 40.88. Now with the previous closing price of 26.79 this now indicates there is a potential upside of 52.6%. The 50 day moving average now sits at 31.63 and the 200 day MA is 30.87. The company has a market cap of $2,780m. You can visit the company''s website by visiting: https://www.evolenthealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EVH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,242m based on the market concensus. Evolent Health, a he... |
Evolent Health: A Bit Complex, But Interesting (NYSE:EVH)Evolent Health''s shares have seen a huge move higher on the back of a substantial deal. Click here to find out why the latest deal looks interesting. |
This Analyst Is Bullish On Evolent Health''s Recent Deal, Calls ''Highly Strategic Acquisition''Thursday after close, Evolent Health Inc (NYSE: EVH ) agreed to acquire Magellan Specialty Health, the specialty benefit management organization owned by Centene Corporation (NYSE: CNC ), for $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance . William Blair is positive on the acquisition and believes this is consistent with management''s prior commentary that Evolent would consider strategic assets … Full story available on Benzinga.com |